Moshe Arkin's Net Worth
$367 Million
Estimate Recalculated Jun 5, 2024 03:16PM EST
Who is Moshe Arkin?
Moshe Arkin has an estimated net worth of $367 Million. This is based on reported shares across multiple companies, which include Orexigen Therapeutics, Inc., Keros Therapeutics, Inc., NeurogesX Inc, PERRIGO CO, Werewolf Therapeutics, Inc., and OPHTHALMIC IMAGING SYSTEMS.
SEC CIK
Moshe Arkin's CIK is 0001321178
Past Insider Trading and Trends
2010 was Moshe Arkin's most active year for acquiring shares with 28 total transactions. Moshe Arkin's most active month to acquire stocks was the month of July. 2008 was Moshe Arkin's most active year for disposing of shares, totalling 989 transactions. Moshe Arkin's most active month to dispose stocks was the month of September. 2021 saw Moshe Arkin paying a total of $6,400,000.00 for 2,046,634 shares, this is the most they've acquired in one year. In 2011 Moshe Arkin cashed out on 2,581,380 shares for a total of $156,827,052.74, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Orexigen Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.34% | -260.00K |
$4.47 | -$1,234,858.00 | 4.61M |
Jul 12 - Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Keros Therapeutics, Inc. (KROS) Snapshot price: $51.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.01M |
$16.00 |
—
| 2.01M |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeurogesX Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -163.47K |
$2.08 | -$339,745.13 |
0
|
Aug 9 - Aug 10
| |||
Form 4
| -4.99% | -8.58K |
$2.10 | -$18,023.80 | 163.47K |
Jun 24 - Jun 27
| |||
Form 4
| -22.52% | -50.00K |
$2.09 | -$104,535.00 | 172.05K |
Jun 23
| |||
Form 4
| -57.47% | -300.00K |
$3.20 | -$961,380.00 | 222.05K |
Jun 16
| |||
Form 4
| -22.62% | -152.60K |
$4.03 | -$615,550.28 | 522.05K |
Mar 24 - Mar 25
| |||
Form 4
| -1.76% | -12.10K |
$4.01 | -$48,536.73 | 674.65K |
Mar 23
| |||
Form 4
| +1.15% | 30K |
$5.50 | $165,000.00 | 2.65M |
Sep 9
| |||
Form 4
| +5.16% | 162.02K |
$7.24 | $1,171,756.48 | 3.3M |
Jan 25 - Feb 10
| |||
Form 4
| +85.09% | 1.44M |
$7.95 | $11,439,816.61 | 3.14M |
Sep 11 - Jan 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PERRIGO CO No price found
Vice Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.53% | -79.86K |
$95.31 | -$7,645,862.55 | 15.07M |
Aug 31
| |||
Form 4
| -3.25% | -170.15K |
$96.46 | -$16,411,795.37 | 5.06M |
Aug 30
| |||
Form 4
| -0.01% | -400.00 |
$87.00 | -$34,800.00 | 5.23M |
May 20
| |||
Form 4
| -3.33% | -180.36K |
$86.46 | -$15,594,887.72 | 5.23M |
May 18 - May 19
| |||
Form 4
| -1.94% | -107.19K |
$87.45 | -$9,374,220.77 | 5.41M |
May 12 - May 13
| |||
Form 4
| -2.28% | -128.73K |
$87.41 | -$11,251,925.08 | 5.52M |
May 10 - May 11
| |||
Form 4
| -3.52% | -206.22K |
$87.47 | -$18,037,770.53 | 5.65M |
May 6 - May 9
| |||
Form 4
| -2.74% | -165.05K |
$86.03 | -$14,199,581.60 | 5.86M |
May 5
| |||
Form 4
| -1.63% | -100.00K |
$76.71 | -$7,671,069.78 | 6.02M |
Mar 2 - Mar 3
| |||
Form 4
| -1.61% | -100.00K |
$48.70 | -$9,535,265.68 | 6.12M |
Feb 28 - Mar 1
| |||
Form 4
| -0.70% | -43.87K |
$75.51 | -$3,312,934.42 | 6.22M |
Feb 25
| |||
Form 4
| -0.45% | -56.13K |
$74.94 | -$4,189,471.25 | 12.54M |
Feb 22
| |||
Form 4
| -3.07% | -200.00K |
$75.69 | -$15,138,420.00 | 6.32M |
Feb 18
| |||
Form 4
| -4.22% | -287.65K |
$75.35 | -$21,611,890.74 | 6.52M |
Feb 16 - Feb 17
| |||
Form 4
| -0.54% | -470.00 |
—
|
—
| 87.18K |
Nov 9
| |||
Form 4
| +7.54% | 6.15K |
—
|
—
| 87.65K |
Aug 30
| |||
Form 4
| +16.27% | 11.41K |
—
|
—
| 81.5K |
Aug 19
| |||
Form 4
| +364.26% | 55K |
$14.90 | $819,650.00 | 70.1K |
Dec 3
| |||
Form 4
| +11.14% | 1.51K |
—
|
—
| 15.1K |
Nov 9
| |||
Form 4
| -0.41% | -27.52K |
$34.01 | -$935,758.62 | 6.72M |
Scheduled
|
Oct 5
| ||
Form 4
| -3.36% | -234.89K |
$34.13 | -$8,015,762.18 | 6.75M |
Scheduled
|
Oct 1
| ||
Form 4
| -0.52% | -36.74K |
$34.03 | -$1,250,081.13 | 6.99M |
Scheduled
|
Sep 29 - Sep 30
| ||
Form 4
| +71.85% | 5.68K |
—
|
—
| 13.59K |
Aug 25
| |||
Form 4
| -2.23% | -160.00K |
$34.35 | -$5,495,984.00 | 7.02M |
Scheduled
|
Nov 28
| ||
Form 4
| -1.06% | -76.90K |
$34.02 | -$2,616,312.19 | 7.18M |
Scheduled
|
Nov 25 - Nov 26
| ||
Form 4
| -0.82% | -60.00K |
$34.07 | -$2,044,146.00 | 7.26M |
Scheduled
|
Nov 14
| ||
Form 4
| -0.25% | -18.55K |
$34.01 | -$680,116.00 | 7.33M |
Scheduled
|
Nov 13
| ||
Form 4
| -0.92% | -68.20K |
$34.83 | -$2,375,146.84 | 7.34M |
Scheduled
|
Nov 4
| ||
Form 4
| -3.84% | -295.60K |
$34.40 | -$10,169,929.75 | 7.41M |
Scheduled
|
Oct 31 - Nov 3
| ||
Form 4
| -0.11% | -8.57K |
$34.01 | -$291,298.82 | 7.7M |
Scheduled
|
Oct 30
| ||
Form 4
| -0.71% | -55.03K |
$34.32 | -$1,888,677.69 | 7.71M |
Scheduled
|
Oct 15 - Oct 16
| ||
Form 4
| -5.48% | -450.00K |
$34.76 | -$15,640,615.41 | 7.77M |
Scheduled
|
Oct 13 - Oct 14
| ||
Form 4
| -0.68% | -56.20K |
$35.10 | -$1,972,566.64 | 8.22M |
Scheduled
|
Oct 9
| ||
Form 4
| -0.35% | -29.19K |
$34.33 | -$1,001,948.08 | 8.27M |
Scheduled
|
Oct 9
| ||
Form 4
| -0.41% | -34.21K |
$34.40 | -$1,177,017.56 | 8.3M |
Scheduled
|
Oct 8 - Oct 9
| ||
Form 4
| -0.19% | -16.19K |
$35.03 | -$566,956.09 | 8.34M |
Scheduled
|
Oct 8
| ||
Form 4
| -0.10% | -25.95K |
$34.85 | -$903,163.66 | 25.07M |
Scheduled
|
Oct 8
| ||
Form 4
| -0.37% | -30.86K |
$34.71 | -$1,071,403.54 | 8.38M |
Scheduled
|
Oct 8
| ||
Form 4
| -0.30% | -25.56K |
$34.63 | -$885,156.29 | 8.41M |
Scheduled
|
Oct 8
| ||
Form 4
| -0.04% | -15.26K |
$34.54 | -$527,309.89 | 42.24M |
Scheduled
|
Oct 8
| ||
Form 4
| -0.26% | -22.19K |
$34.51 | -$765,689.43 | 8.45M |
Scheduled
|
Oct 8
| ||
Form 4
| -0.26% | -43.79K |
$34.46 | -$1,507,389.59 | 16.95M |
Scheduled
|
Oct 8
| ||
Form 4
| -0.06% | -5.50K |
$36.23 | -$199,237.98 | 8.52M |
Scheduled
|
Oct 7
| ||
Form 4
| -0.18% | -15.53K |
$36.14 | -$561,301.25 | 8.52M |
Scheduled
|
Oct 7
| ||
Form 4
| -0.31% | -26.27K |
$36.10 | -$948,376.85 | 8.54M |
Scheduled
|
Oct 7
| ||
Form 4
| -0.06% | -14.50K |
$36.02 | -$522,399.75 | 25.71M |
Scheduled
|
Oct 7
| ||
Form 4
| -0.74% | -64.18K |
$36.00 | -$2,310,194.92 | 8.58M |
Scheduled
|
Oct 7
| ||
Form 4
| -0.29% | -24.92K |
$35.90 | -$894,524.49 | 8.64M |
Scheduled
|
Oct 7
| ||
Form 4
| -0.23% | -20.30K |
$35.84 | -$727,633.33 | 8.67M |
Scheduled
|
Oct 7
| ||
Form 4
| -0.23% | -19.81K |
$35.77 | -$708,516.64 | 8.69M |
Scheduled
|
Oct 7
| ||
Form 4
| -0.16% | -40.70K |
$35.68 | -$1,454,352.56 | 25.87M |
Scheduled
|
Oct 7
| ||
Form 4
| -0.21% | -18.44K |
$36.67 | -$676,246.94 | 8.75M |
Scheduled
|
Oct 7
| ||
Form 4
| -0.20% | -17.13K |
$35.51 | -$608,163.25 | 8.77M |
Scheduled
|
Oct 7
| ||
Form 4
| -0.37% | -32.63K |
$35.38 | -$1,154,460.78 | 8.78M |
Scheduled
|
Oct 7
| ||
Form 4
| -0.15% | -13.60K |
$35.64 | -$484,708.01 | 8.82M |
Scheduled
|
Oct 6 - Oct 7
| ||
Form 4
| -0.15% | -13.69K |
$35.56 | -$486,651.63 | 8.83M |
Scheduled
|
Oct 6
| ||
Form 4
| -0.19% | -17.00K |
$35.17 | -$597,898.42 | 8.84M |
Scheduled
|
Oct 6
| ||
Form 4
| -0.31% | -27.91K |
$35.04 | -$978,264.26 | 8.86M |
Scheduled
|
Oct 6
| ||
Form 4
| -0.24% | -21.20K |
$34.99 | -$741,697.13 | 8.89M |
Scheduled
|
Oct 6
| ||
Form 4
| -0.17% | -15.50K |
$34.76 | -$538,772.14 | 8.91M |
Scheduled
|
Oct 6
| ||
Form 4
| -0.19% | -17.30K |
$34.71 | -$600,476.51 | 8.92M |
Scheduled
|
Oct 6
| ||
Form 4
| -0.12% | -11.10K |
$34.59 | -$383,912.61 | 8.94M |
Scheduled
|
Oct 6
| ||
Form 4
| -0.25% | -22.80K |
$34.28 | -$781,657.48 | 8.95M |
Scheduled
|
Oct 6
| ||
Form 4
| -0.04% | -3.84K |
$34.80 | -$133,527.60 | 8.98M |
Sep 5
| |||
Form 4
| -0.00% | -400.00 |
$34.97 | -$13,989.00 | 8.98M |
Sep 3
| |||
Form 4
| -1.05% | -95.55K |
$34.91 | -$3,335,583.23 | 8.98M |
Sep 3
| |||
Form 4
| -0.19% | -17.89K |
$36.05 | -$645,055.69 | 9.51M |
Aug 25
| |||
Form 4
| -0.46% | -44.00K |
$36.25 | -$1,594,868.25 | 9.58M |
Aug 22
| |||
Form 4
| -0.58% | -56.00K |
$36.48 | -$2,042,973.18 | 9.53M |
Aug 22
| |||
Form 4
| -0.90% | -87.26K |
$35.95 | -$3,137,056.05 | 9.63M |
Aug 21
| |||
Form 4
| -1.22% | -119.56K |
$35.75 | -$4,274,131.05 | 9.71M |
Aug 21
| |||
Form 4
| -0.94% | -93.17K |
$35.55 | -$3,312,084.83 | 9.83M |
Aug 20 - Aug 21
| |||
Form 4
| -0.48% | -45.90K |
$35.59 | -$1,633,497.57 | 9.49M |
Feb 26
| |||
Form 4
| -0.66% | -62.93K |
$35.24 | -$2,217,826.07 | 9.54M |
Feb 2 - Feb 26
| |||
Form 4
| -0.75% | -72.64K |
$35.26 | -$2,561,133.50 | 9.6M |
Feb 6 - Feb 26
| |||
Form 4
| -0.71% | -206.04K |
$35.36 | -$7,270,315.74 | 29M |
Feb 25
| |||
Form 4
| -0.45% | -44.93K |
$35.01 | -$1,573,222.60 | 9.88M |
Feb 21
| |||
Form 4
| -0.02% | -1.55K |
$35.75 | -$55,406.50 | 9.93M |
Feb 19
| |||
Form 4
| -0.32% | -94.77K |
$35.34 | -$3,350,979.51 | 29.88M |
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 30
| |||
Form 4
|
∞
| 6.45K |
—
|
—
| 6.45K |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 4
|
∞
| 10.02M |
—
|
—
| 10.02M |
Mar 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Werewolf Therapeutics, Inc. (HOWL) Snapshot price: $6.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.05M |
$16.00 |
—
| 2.05M |
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||